Dennis Cho
Vermogen: 8 M $ op 31-05-2026
Vermogen: 8 M $ op 31-05-2026
Momenteel is Dennis Hohn Cho Senior VP, Chief Ethics & Compliance Officer bij Twist Bioscience Corp. In het verleden bekleedde de heer Cho de functie van Assistant General Counsel bij CytomX Therapeutics, Inc. en SVP-Business Affairs & General Counsel bij Image Entertainment, Inc. Hij is afgestudeerd aan de University of California, Berkeley.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-06-2026 | 119.346 ( 0,19% ) | 8 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Algemeen Adviseur | 27-09-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Directeur/Bestuurslid | 01-01-2021 |
| CELGENE | Directeur/Bestuurslid | 01-12-2019 |
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Distributes home entertainment programming on different formats and platforms | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Distributes home entertainment programming on different formats and platforms | Consumer Services |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Twist Bioscience Corp.
Twist Bioscience Corp. BiotechnologyHealth Technology Manufactures, distributes and sells synthetic DNA products through online | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau